rxstatShortages › Bupivacaine

Bupivacaine (Marcaine, Sensorcaine) shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 29, 2026

Also sold as: Marcaine, Sensorcaine, Marcaine Spinal

Some Bupivacaine products are in shortage in Canada (4 of 15 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 31, 2027.

A local anesthetic used to numb an area of the body during surgery, dental work or childbirth.

Products affected
4 / 15
In shortage since
Jan 31, 2018
Est. full return
Jan 31, 2027
Reports on file
55
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Book a pharmacist appointment
Need your prescription switched?
If your product stays unavailable, an online doctor can assess your situation and prescribe an alternative.
See a doctor online

Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Active shortage
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
7.5MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02512424 · since Jun 22, 2026, est. end Jan 31, 2027 · Disruption of the manufacture of the drug.
Active shortage
MARCAINE
5.0MG · SOLUTION · PFIZER CANADA INC
DIN 02241919 · since Feb 21, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MARCAINE
2.5MG · SOLUTION · PFIZER CANADA INC
DIN 02241918 · since Mar 30, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MARCAINE
2.5MG · SOLUTION · PFIZER CANADA INC
DIN 02241918 · since Mar 20, 2018, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MARCAINE
5.0MG · SOLUTION · PFIZER CANADA INC
DIN 02241919 · since Jan 9, 2019, no end estimate · Disruption of the manufacture of the drug.
Active shortage
MARCAINE
2.5MG · SOLUTION · PFIZER CANADA INC
DIN 02305895 · since Jan 31, 2018, no end estimate · Disruption of the manufacture of the drug.
Anticipated
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
7.5MG · SOLUTION · FORMATIVE PHARMA INC.
DIN 02536714 · Requirements related to complying with good manufacturing practices.
To be discontinued
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
7.5MG · SOLUTION · STERIMAX INC
DIN 02460645
Resolved
BUPIVACAINE HYDROCHLORIDE IN DEXTROSE INJECTION USP
7.5MG · SOLUTION · OMEGA LABORATORIES LIMITED
DIN 02512424 · ended Sep 11, 2025 · Requirements related to complying with good manufacturing practices.
Resolved
BUPIVACAINE INJECTION BP
2.5MG · SOLUTION · STERIMAX INC
DIN 02443686 · ended Dec 19, 2024 · Disruption of the manufacture of the drug.
Resolved
SENSORCAINE
5MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 01976168 · ended Oct 25, 2024 · Disruption of the manufacture of the drug.
Resolved
SENSORCAINE
2.5MG · SOLUTION · ASPEN PHARMACARE CANADA INC.
DIN 01976141 · ended Oct 25, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 55 reports. All reports are on file with Health Canada.

What's happening

Bupivacaine is currently affected by 4 active shortage reports filed with Health Canada by OMEGA LABORATORIES LIMITED, PFIZER CANADA INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Bupivacaine is classified under “ANESTHETICS, LOCAL” (ATC N01BB).

Recent changes

Common questions

What is Bupivacaine used for?

A local anesthetic used to numb an area of the body during surgery, dental work or childbirth.

When will Bupivacaine be back in stock in Canada?

The latest manufacturer estimate is Jan 31, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Bupivacaine in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (anesthetics, local)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.